greeksoup/ stock research

Protagonist Therapeutics, Inc. 13F holders

Of the 44 funds followed here, 6 reported a position in Protagonist Therapeutics, Inc. in a 13F for the quarter ended 30 June 2026. The largest: Geode Capital Management, 1.7 million shares worth $213.5 million, 0.0% of its reported book.

FundSharesValueOf its bookChange on the quarterStatusQuarter endedFiling
Geode Capital Management1,741,209$213.5 million0.0%+71,838added30 June 202613F
Alyeska889,298$109.0 million0.3%+296,101added30 June 202613F
FMR LLC672,186$82.4 million0.0%+10,189added30 June 202613F
Duquesne Family Office208,900$25.6 million0.5%+49,200added30 June 202613F
Citadel Advisors45,800$5.6 million0.0%-1,558,600trimmed30 June 202613F
Bridgewater Associates9,269$1.1 million0.0%+3,993added30 June 202613F
Value is what the fund reported.
Read moreChange is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.

Schedule 13D and 13G filed on the name, last twelve months

FiledScheduleWhoHoldingOf the classEvent dateRule or purposeFiling
13 August 202613G/AFarallon Capital Management, L.L.C. and 57 others6.4 million10.0%30 June 2026passive, institutional (13d-1(b))EDGAR
7 August 202613GState Street Corporation and 1 other3.3 million5.2%30 June 2026passive, institutional (13d-1(b))EDGAR
12 May 202613GState Street Corporation and 1 other3.1 million4.9%31 March 2026passive, institutional (13d-1(b))EDGAR
30 April 202613GVanguard Capital Management and 1 other3.3 million5.1%31 March 2026passive, institutional (13d-1(b))EDGAR
29 April 202613GVanguard Portfolio Management and 1 other3.5 million5.5%31 March 2026passive, institutional (13d-1(b))EDGAR
27 March 202613G/AThe Vanguard Group and 1 other00.0%13 March 2026passive, institutional (13d-1(b))EDGAR
17 February 202613G/ARTW Investments, LP and 3 others5.1 million8.1%31 December 2025passive, institutional (13d-1(b))EDGAR
10 February 202613GWellington Management Group LLP and 5 others3.2 million5.1%31 December 2025passive, institutional (13d-1(b))EDGAR
6 February 202613G/AFarallon Capital Partners, L.P. and 61 others6.2 million10.0%31 December 2025passive, under 20% (13d-1(c))EDGAR
30 January 202613G/AThe Vanguard Group and 1 other5.4 million8.7%31 December 2025passive, institutional (13d-1(b))EDGAR
14 November 202513G/ADeep Track Capital, LP and 5 others1.7 million2.8%30 September 2025passive, under 20% (13d-1(c))EDGAR
14 November 202513G/ABiotechnology Value Fund L P and 19 others2.6 million4.1%30 September 2025passive, under 20% (13d-1(c))EDGAR
17 October 202513G/ABlackRock, Inc. and 1 other8.6 million13.8%30 September 2025passive, institutional (13d-1(b))EDGAR
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read moreAmendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short.

Fails to deliver

Settlement dateShares failedPriceFile
9 September 202628,995$145.94SEC
3 September 202647,443$146.08SEC
2 September 20261,629$146.49SEC
26 August 20262,090$150.59SEC
19 August 20262,100$157.34SEC
6 August 202694$137.32SEC
4 August 20262$132.28SEC
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.
Read moreLargest in the window: 47,443 on 3 September 2026. A fail is an operational fact about settlement, not a position.

Source

Each fund's 13F-HR on EDGAR, linked per row; positions matched to PTGX by CUSIP from the SEC's own fails-to-deliver files; Schedule 13D and 13G from the company's own filing index, each read to confirm the company is the issuer named.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install